Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

Lymphoma, Burkitt

  • Dana-Farber / Children's Hospital Cancer Center logo

    Burkitt lymphoma is a fast-growing type of B-cell non-Hodgkin lymphoma that occurs most often in children and young adults. The disease may affect the jaw, central nervous system, kidneys, ovaries, or other organs. Learn about Burkitt lymphoma and find information on how we support and care for children and teens with Burkitt lymphoma before, during, and after treatment.

The Hematologic Malignancy Center at Dana-Farber Boston Children's Cancer and Blood Disorders Center is one of the top pediatric leukemia and lymphoma treatment centers in the world. In addition to treating lymphomas and leukemias, our center treats the primary types of histiocytosis.

All members of our treatment team — including oncologists, radiation oncologists, surgeons, stem cell transplant physicians and oncology nurses — have specific expertise in pediatric hematologic malignancies. Many of our specialists are recognized as national leaders in their field.

Our clinical research program enables us to offer innovative clinical trials for children of all ages and with many forms of hematologic malignancies. Our clinical team works closely with researchers to develop new treatments based on the latest scientific discoveries.

Our services include:

  • expert hematopathologic evaluation using advanced diagnostic techniques
  • an individualized treatment plan tailored to your child's needs
  • an internationally recognized pediatric stem cell transplant program
  • innovative treatment options for all types of pediatric hematologic malignancies

Additional support services for our patients include:

  • psychologists and social workers for all patients, siblings and parents
  • complementary therapies consultation and treatment integrated into the comprehensive care plan
  • the services of other specialists as needed, including experts in cardiology, pulmonary, endocrinology, reproductive and gynecologic services, neurology, anesthesia, dermatology, nutrition, and physical therapy
  • a survivorship clinic that offers clinical and support resources to address the medical and psychosocial challenges of being a cancer survivor.

Learn more about our Hematologic Malignancy Center.

Burkitt’s Lymphoma


Burkitt's lymphoma (also called small noncleaved cell lymphoma) is a type of non-Hodgkin's lymphoma, a cancer in the lymphatic system.

  • Non-Hodgkin's lymphoma causes the cells in your child’s lymphatic system to abnormally reproduce, eventually causing tumors to grow.
  • Non-Hodgkin's disease cells can also spread to other organs and tissues in the body.
  • Non-Hodgkin's lymphoma is the third most common childhood cancer.
  • It occurs most often in children between the ages of 7 and 11, but can occur at any age from infancy to adulthood.
  • Non-Hodgkin's lymphoma affects males almost three times more often than females, and is more common among Caucasian children than among African-American children and children of other races.

Children with Burkitt's lymphoma are treated through the Lymphoma Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We utilize the expertise of both Boston Children's Hospital, consistently ranked one of the top children's hospital in the country, and Dana-Farber Cancer Institute, a nationally recognized leader in cancer care and a member of the Dana-Farber/Harvard Cancer Center. Members of our physician team all have specific expertise in pediatric lymphomas.


What is the lymphatic system?

The lymphatic system is part of the immune system and functions to fight disease and infections. The lymphatic system includes:

  • lymphocytes - specific white blood cells that fight infections and disease. The two main types of lymphocytes are B-cells and T-cells. Normal B-cells mature into plasma cells and produce immunoglobulins (also called antibodies) that help protect the body from bacteria. Normal T-cells serve in several roles to help protect the body. They recognize and destroy virus-infected cells, and they help attract other white blood cells that kill infected cells. There are several types and different stages of maturation for these cells.
  • lymph fluid - fluid containing lymphocyte cells
  • lymph vessels - thin tubes that carry lymph fluid throughout the body, like blood vessels
  • lymph nodes - bean-shaped organs, found in the underarm, groin, neck, chest, and abdomen, that act as filters for the lymph fluid as it circulates through your child’s body
  • spleen - a small organ that produces lymphocytes, stores healthy blood cells, and filters out damaged blood cells, bacteria and cell waste
  • thymus - a small gland, located in front of the heart, that plays a vital role in the development of T-cells while the child is still in the womb. Although the size of the gland starts to decrease after young adulthood, it continues to serve as part of the immune system throughout life.
  • bone marrow/stem cells - the bone marrow contains stem cells, cells that develop into red blood cells, platelets (clotting cells) and infection-fighting white blood cells, including lymphocytes. Stem cells are also found circulating throughout the body in the blood stream.
How does Burkitt’s lymphoma differ from other non-Hodgkin’s lymphomas?

There are several types of non-Hodgkin's lymphomas, classified by physicians based on the size and shape of the lymphoma cells under a microscope, and how the cells grow within the lymph nodes and beyond.

  • Burkitt's lymphoma has what are considered small cells that are “noncleaved,” meaning the have no folds or indentations when viewed under a microscope.
  • Burkitt's lymphoma usually develops in the abdomen and spreads to other organs, including the brain.
  • Burkitt's lymphoma involves B-cells and is a rapidly growing cancer.
  • There is also a type of small, noncleaved lymphoma that has a somewhat different appearance under the microscope that is called non-Burkitt's lymphoma, which usually occurs in adults.
What causes Burkitt's lymphoma?

The specific cause of non-Hodgkin's lymphoma is unclear.  Some possibilities for factors that may increased your child’s risk of developing this cancer include:

  • genetics
  • exposure to viral infections
  • Non-Hodgkin's lymphoma has also been linked to chemotherapy and radiation therapy—it may be a second malignancy as a result of the treatment for certain cancers.

There has been much investigation into the association of non-Hodgkin’s lymphoma with:

  • the Epstein-Barr virus (EBV), which causes the infection mononucleosis (mono)
  • human immunodeficiency virus (HIV), which causes acquired immune deficiency syndrome (AIDS)

Both of these infectious viruses have been linked to the development of Burkitt's lymphoma.

The majority of Burkitt's lymphoma cases result from a chromosome rearrangement between chromosome #8 and #14, which causes genes to change positions and function differently, promoting uncontrolled cell growth.

Other chromosome rearrangements have been seen in non-Hodgkin's lymphoma (all types) are also thought to promote excessive cell growth. Children and adults with other hereditary abnormalities have an increased risk of developing non-Hodgkin's lymphoma, including patients with:

  • ataxia telangiectasia
  • X-linked lymphoproliferative disease
  • the Wiskott-Aldrich syndrome
What are the symptoms of non-Hodgkin's lymphoma?

Most children have stage III or IV disease at the time of diagnosis because of the sudden onset of symptoms. The disease can progress quickly from a few days to a few weeks, and your child could go from otherwise healthy to having multi-system involvement in a short time period.

Some children with non-Hodgkin's lymphoma have symptoms of an abdominal mass and complain of abdominal pain, fever, constipation and decreased appetite (due to the pressure and obstruction a large tumor in this area can cause). Some children with non-Hodgkin's lymphoma have symptoms of a mass in their chest and complain of respiratory problems, dyspnea (pain with deep breaths), cough and/or wheezing.

Because of the rapid onset of this malignancy, any respiratory symptoms can quickly worsen, causing a life-threatening emergency.

While each child may experience symptoms differently, some of the most common include: 

  • painless swelling of the lymph nodes in neck, chest, abdomen, underarm or groin
  • fever
  • sore throat
  • fullness in groin area from node involvement
  • bone and joint pain
  • night sweats
  • tiring easily
  • weight loss/decreased appetite
  • itching of the skin
  • recurring infections

The symptoms of non-Hodgkin's lymphoma may resemble other blood disorders or medical problems. Always consult your child's physician for a diagnosis.


How is non-Hodgkin's lymphoma diagnosed?

In addition to a complete medical history and physical examination, diagnostic procedures for non-Hodgkin's lymphoma may include: 

  • blood and urine tests
  • x-rays of the chest - a diagnostic test which uses invisible electromagnetic energy beams to produce images of your child’s internal tissues, bones, and organs onto film
  • lymph node biopsy - a sample of tissue is removed from a lymph node and examined under a microscope
  • computerized tomography scan (also called a CT or CAT scan) - a diagnostic imaging procedure that uses a combination of x-rays and computer technology to produce cross-sectional images (often called slices), both horizontally and vertically, of the body. A CT scan shows detailed images of any part of the body, including the bones, muscles, fat and organs. CT scans are more detailed than general x-rays.
  • lymphangiogram (LAG) - Dye is injected into lymphatic system to determine how much it is involved in areas that are otherwise difficult to visualize.
  • bone marrow biopsy/aspiration - a procedure that involves a small amount of bone marrow fluid and tissue to be taken, usually from part of the hip bones, to further examine the number, size, and maturity of blood cells and/or abnormal cells.
  • lumbar puncture (to evaluate central nervous system disease for cancer cells) - a special needle is placed into your child’s lower back, into the spinal canal. This is the area around the spinal cord. A small amount of cerebral spinal fluid (CSF) can be removed and sent for testing. CSF is the fluid that bathes the brain and spinal cord.
How is non-Hodgkin's lymphoma staged?

Staging is the process of determining whether cancer has spread and, if so, how far. There are various staging symptoms that are used for non-Hodgkin's lymphoma. Always consult your child's physician for information on staging.

One method of staging non-Hodgkin's lymphoma is the following:

  • stage I - involves the tumor at one site, either nodal or elsewhere in the body
  • stage II - involves the tumor at two or more sites on the same side of the body
  • stage III - involves tumors in any number that occur on both sides of the body, but does not involve bone marrow or the central nervous system
  • stage IV - is any stage of tumor that also has bone marrow and/or central nervous system involvement. Stage IV is also subdivided depending on the amount of blasts (cancer cells) present in the bone marrow.

Treatment and care

What is the treatment for Burkitt’s lymphoma?

Specific treatment for Burkitt’s lymphoma will be determined by your child's physician based on:

  • your child's age, overall health and medical history
  • the extent of the disease
  • your child's tolerance for certain medications, procedures or therapies
  • how your child's physician expects the disease to progress
  • your opinion or preference

Treatment components may include the following (alone or in combination):

Chemotherapy is a drug treatment that works by interfering with the cancer cell's ability to grow or reproduce. Because Burkitt's lymphoma grows so quickly, chemotherapy treatment may be intense and last 6-8 months. Treatment may include drugs given directly to central nervous system (CNS) through the blood stream or a small puncture in the spine to prevent cancerous cells from multiplying in the spinal cord or brain.

— How is chemotherapy given? Different chemotherapies may be given:

  • as a pill to swallow
  • as an injection into the muscle or fat tissue
  • intravenously (directly to the bloodstream, also called IV)
  • intrathecally (directly into the spinal column with a needle)

— How is chemotherapy used? This depends on many factors. Some things to keep in mind:

  • A number of combinations of chemotherapy drugs are currently being used to stabilize and, in some cases, to shrink the size of the tumor.
  • Depending on the type of cancer, chemotherapy drugs may be given in a specific order.
  • Chemotherapy may be used alone for some types of cancer, or in conjunction with other therapy such as radiation or surgery.

— Does chemotherapy come with bad side effects? While chemotherapy can be quite effective, the drugs do not differentiate normal healthy cells from cancer cells. Because of this, there can be many adverse side effects during treatment. Being able to anticipate these side effects can help your child, family and your child’s health care team prepare for and sometimes prevent these symptoms from occurring.

Surgery usually plays a limited role in the treatment of lymphoma. In some instances, a child may need to have a tumor removed. This may be the case if, for example, the tumor originates in the mediastinum region, where it may compress your child’s airway and/or heart and major vessels. Surgery in this area may entail considerable risk, and must be carefully orchestrated between the surgeon, oncologist and anesthesiologist.

Radiation therapy
Radiation therapy uses high-energy rays (radiation) from a specialized machine to damage or kill cancer cells and shrink tumors. This type of therapy is most effective when there is a bulky, localized tumor that will not respond completely to chemotherapy.

Stem cell transplant
Stem cells are a specific type of cell from which all blood cells develop. They can develop into red blood cells to carry oxygen, white blood cells to fight disease and infection, and platelets to aid in blood clotting. Stem cells are found primarily in the bone marrow, but some also circulate in the blood stream.

  • Treatment with stem cell transplant (also called bone marrow transplant) may begin with high-dose chemotherapy (perhaps combined with radiation therapy) to destroy all of the bone marrow, stem cells and cancerous cells, in your child’s body.
  • Then, healthy stem cells collected from another individual whose tissue is the same as, or almost the same as, the patients are used. This is called allogeneic transplantation. This is the most common type of stem cell transplant used to treat lymphoblastic lymphoma. Often, stem cell transplant is most appropriate for patients who have recurrent or drug-resistant disease.
  • Sometimes, your child’s own stem cells are collected prior to intensive treatment and used to supplement recovery after a particularly aggressive course of treatment. Through this procedure, stem cells are taken, treated in a laboratory to kill any remaining cancer cells, and kept in frozen storage for later use. After chemotherapy and/or radiation therapy, the saved stem cells are thawed and given back to grow new bone marrow and other stem cells. This is known as autologous transplantation.

Supportive care
Medications including antibiotics may be given if your child experiences pain, fever, infection and nausea and/or vomiting.

Continuous follow-up care

Your child’s health will be closely monitored to determine response to treatment, detect recurrent disease and manage late effects of treatment.

What is the long-term outlook for a child with Burkitt’s lymphoma?

Your child’s prognosis greatly depends on:

  • the extent of the disease
  • presence or absence of metastasis
  • response to therapy
  • your child’s age and overall health
  • tolerance of specific medications, procedures or therapies
  • new developments in treatment

As with any cancer, prognosis and long-term survival can vary greatly. Prompt medical attention and aggressive therapy are important for the best prognosis, and continuous follow-up care is essential. New methods are continually being discovered to improve treatment and decrease side effects of the treatment for the disease.

What is the latest research on Burkitt’s Lymphoma?

A variety of chemotherapeutic regimens have been evaluated in the treatment of newly diagnosed high-grade gliomas.

  • While studies in adults have suggested that procarbazine, vincristine and CCNU (PVC) produce modest responses in grade III gliomas, this has not been demonstrated for pediatric cases or for grade IV tumors.
  • Several other regimens have also produced responses, but none has improved survival.
  • Increased doses of chemotherapy in the setting of autologous bone marrow transplant have also not produced notable advantage.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is part of the Children's Oncology Group, a national group of pediatric oncologists whose work includes investigational treatments for newly diagnosed patients with non-Hodgkin's lymphoma and those who experience relapse. Studies also seek to improve the supportive care of patients undergoing treatment.

One area of treatment under investigation is biological therapy or immunotherapy, the use of drugs that seem to slow the growth of cancer cells while stimulating and strengthening the body's own immune system. Improvements are also occurring in the area of stem cell transplant, where researchers are finding better ways to improve pre-transplant treatment, broaden the range of compatible donors, and more effectively remove cancerous cells from patient's own bone marrow.

  •   Email
  •   Print
  •   Share
  • Make an Appointment

    • For adults:
      877-442-3324 (877-442-DFCI)

    • Quick access:
      Appointments as soon as the next day for new adult patients

    • For children:
      888-733-4662 (888-PEDI-ONC)

    • Make Appointment Online
  • Find a Clinical Trial

  • Ranked #1 for Children

    • U.S. News and World Report Best Children's Hospital Cancer logo Dana-Farber/
      Boston Children's is ranked the #1 pediatric cancer hospital by the U.S. News & World Report 2016-17 Best Children's Hospitals guide.